Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9BUT1
UPID:
DHRS6_HUMAN
Alternative names:
(R)-beta-hydroxybutyrate dehydrogenase; 3-hydroxybutyrate dehydrogenase type 2; 4-oxo-L-proline reductase; Oxidoreductase UCPA; Short chain dehydrogenase/reductase family 15C member 1
Alternative UPACC:
Q9BUT1; A8K295; B4DUF6; Q503A0; Q6IA46; Q6UWD3; Q9H8S8; Q9NRX8
Background:
Dehydrogenase/reductase SDR family member 6, known by alternative names such as (R)-beta-hydroxybutyrate dehydrogenase and 4-oxo-L-proline reductase, plays a crucial role in cellular processes. It functions as an NAD(H)-dependent dehydrogenase/reductase, preferring cyclic substrates. This protein is pivotal in the stereoselective conversion of 4-oxo-L-proline to cis-4-hydroxy-L-proline, a potential detoxification pathway for ketoprolines. Additionally, it facilitates the formation of 2,5-dihydroxybenzoate, a siderophore essential for iron transport and homeostasis, thereby protecting cells from oxidative stress.
Therapeutic significance:
Understanding the role of Dehydrogenase/reductase SDR family member 6 could open doors to potential therapeutic strategies.